Key result
Longitudinal SBP and DBP trajectories are linked to earlier cardiovascular complications in hypertensive patients.
Why the study?
Hypertension is a leading contributor to cardiovascular disease complications, but the factors influencing longitudinal blood pressure trajectories and time to cardiovascular complications required identification.
What factors affect longitudinal blood pressure outcomes and survival time for cardiovascular disease complications among patients with hypertension?
Cohort (n=178)
No
What factors affect longitudinal blood pressure outcomes and survival time for cardiovascular disease complications among patients with hypertension?
Effect estimate: Association parameter 0.0655 for SBP and 0.963 for DBP
p-value: p=0.0270 (SBP), 0.0387 (DBP)
Joint modeling of longitudinal blood pressure and survival data highlights the importance of managing comorbidities like diabetes and monitoring patients with a family history of hypertension to prevent cardiovascular complications.
Introduction: Hypertension is also referred to as a silent killer and a leading factor for cardiovascular disease complication in the world today. This study aimed to identify the factors that affect longitudinal outcomes and survival time for cardiovascular disease complications among patients with hypertension. Methods: A retrospective cohort study was conducted among a randomly selected sample of 178 outpatients with hypertension at the Debre Tabor Specialized Hospital between September 2017 and December 2019. Three different models were used to analyze the data: the bivariate mixed-effects model, Cox proportional hazard model, and bivariate joint model for longitudinal and survival sub-models linked by shared random effects. Results: Bivariate mixed-effects and Cox proportional hazards survival sub-models were jointly preferred based on the minimum Akaike Information Criterion value. The estimated values of the association parameters were 0.0655 (p = 0.0270) and 0.963 (p = 0.0387), indicating that the association between systolic and diastolic blood pressure with time to event was guaranteed. The joint bivariate mixed-effects model analysis showed that patients with hypertension with a family history of hypertension and clinical stage II hypertension have a high chance of developing cardiovascular disease complications and have high average systolic and diastolic blood pressure compared to their counterparts. Patients with hypertension and diabetes have higher systolic and diastolic blood pressure than their counterparts. Conclusion: Generally, systolic and diastolic blood pressure stabilized over the follow-up period of treatment, while sex and residence were statistically insignificant to the survival time of cardiovascular disease complication. Health professionals and concerned bodies should therefore focus on patients with comorbidities, older age, and poor adherence to hypertension control and cardiovascular disease complications using technology, such as text messaging, and mobile application to promote cardiovascular health at early stage. It is important to provide early interventions for these groups of people, especially for those with family history.
No takes yet. Share an insight, caveat, or question.
Zelelew et al. (2023) conducted a cohort in Hypertension (n=178). Longitudinal blood pressure and baseline risk factors (diabetes, family history of hypertension, clinical stage II hypertension) vs. Patients without these risk factors was evaluated on Time to cardiovascular disease complication (Association parameter 0.0655 for SBP and 0.963 for DBP, p=0.0270 (SBP), 0.0387 (DBP)). Longitudinal systolic and diastolic blood pressure measurements were significantly associated with the time to cardiovascular disease complications among hypertensive patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: